Studies are proposed to define the role of vasopressin (AVP) in the normal regulation of renal medullary blood flow. We hypothesize that the actions of AVP on the medullary circulation provide a vital link to optimize the ability of the kidney to retain or lose body fluids. Preliminary studies indicate that AVP secretion has a profound influence on the pressure- diuresis.natriuresis relationship whereby in times of volume expansion medullary flow is increased by reduction of AVP with the opposite occurring in times of fluid retention.
Three specific aims and 9 protocols are proposed in rats: 1) determine the effects of small physiological changes of plasma AVP on medullary blood flow and associated changes of the pressure-diuresis-natriuresis relationships in decerebrate rats and unanesthetized rats using implanted optical fiber and laser-Doppler flowmetry; 2) functionally localize medullary vascular sites where AVP modulates blood flow using micropuncture techniques; and localize vascular VI and V2 receptors in microdissected vessels from the cortical and medullary circulation using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting techniques; and 3) evaluate the consequences of these mechanisms in the long-term control of arterial pressure and determine why chronic administration of a specific VI agonist causes sustained hypertension while administration of AVP does not. The role of V2 receptor stimulation via nitric oxide (NO), bradykinin, and prostaglandins in opposing the hypertensive effects of AVP will be examined. The studies will utilize techniques ranging from chronically instrumented, unanesthetized rats to molecular biology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL049219-07
Application #
2857814
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1993-01-01
Project End
2000-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Physiology
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Mori, Takefumi; Polichnowski, Aaron; Glocka, Padden et al. (2008) High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol 19:1472-82
Mori, Takefumi; O'Connor, Paul M; Abe, Michiaki et al. (2007) Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk. Hypertension 49:1336-41
O'Connor, Paul M; Cowley Jr, Allen W (2007) Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway. Am J Physiol Renal Physiol 293:F526-32
Abe, Michiaki; O'Connor, Paul; Kaldunski, Mary et al. (2006) Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol 291:F350-7
Morrison, Jolean; Knoll, Kristen; Hessner, Martin J et al. (2004) Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol Genomics 17:271-82
Cowley Jr, Allen W; Mori, Takefumi; Mattson, David et al. (2003) Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284:R1355-69
Yuan, Baozhi; Liang, Mingyu; Yang, Zhizhang et al. (2003) Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II. Am J Physiol Regul Integr Comp Physiol 284:R1219-30
Mori, Takefumi; Dickhout, Jeffrey G; Cowley Jr, Allen W (2002) Vasopressin increases intracellular NO concentration via Ca(2+) signaling in inner medullary collecting duct. Hypertension 39:465-9
Yuan, B; Cowley Jr, A W (2001) Evidence that reduced renal medullary nitric oxide synthase activity of dahl s rats enables small elevations of arginine vasopressin to produce sustained hypertension. Hypertension 37:524-8
Szentivanyi Jr, M; Park, F; Maeda, C Y et al. (2000) Nitric oxide in the renal medulla protects from vasopressin-induced hypertension. Hypertension 35:740-5

Showing the most recent 10 out of 19 publications